ACLX
Price
$65.81
Change
-$0.76 (-1.14%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
3.56B
56 days until earnings call
ATXS
Price
$7.51
Change
-$0.06 (-0.79%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
423.26M
42 days until earnings call
Ad is loading...

ACLX vs ATXS

Header iconACLX vs ATXS Comparison
Open Charts ACLX vs ATXSBanner chart's image
Arcellx
Price$65.81
Change-$0.76 (-1.14%)
Volume$27.2K
Capitalization3.56B
Astria Therapeutics
Price$7.51
Change-$0.06 (-0.79%)
Volume$13.7K
Capitalization423.26M
ACLX vs ATXS Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. ATXS commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and ATXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (ACLX: $65.85 vs. ATXS: $7.50)
Brand notoriety: ACLX and ATXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 162% vs. ATXS: 74%
Market capitalization -- ACLX: $3.56B vs. ATXS: $423.26M
ACLX [@Biotechnology] is valued at $3.56B. ATXS’s [@Biotechnology] market capitalization is $423.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileATXS’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • ATXS’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while ATXS’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 3 bearish.
  • ATXS’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -2.46% price change this week, while ATXS (@Biotechnology) price change was -3.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

ATXS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.56B) has a higher market cap than ATXS($423M). ACLX YTD gains are higher at: -14.135 vs. ATXS (-16.107). ACLX has higher annual earnings (EBITDA): -33.12M vs. ATXS (-100.97M). ACLX has more cash in the bank: 574M vs. ATXS (344M). ATXS has less debt than ACLX: ATXS (5.64M) vs ACLX (65.3M). ACLX has higher revenues than ATXS: ACLX (156M) vs ATXS (0).
ACLXATXSACLX / ATXS
Capitalization3.56B423M842%
EBITDA-33.12M-100.97M33%
Gain YTD-14.135-16.10788%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash574M344M167%
Total Debt65.3M5.64M1,158%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXATXS
RSI
ODDS (%)
N/A
Bullish Trend 16 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 16 days ago
88%
N/A
Momentum
ODDS (%)
Bearish Trend 16 days ago
68%
N/A
MACD
ODDS (%)
Bearish Trend 16 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
75%
Bearish Trend 16 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
72%
Bearish Trend 16 days ago
87%
Advances
ODDS (%)
Bullish Trend 21 days ago
89%
Bullish Trend 22 days ago
84%
Declines
ODDS (%)
Bearish Trend 24 days ago
76%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 16 days ago
82%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RICGX59.860.25
+0.42%
American Funds Invmt Co of Amer R6
GCBLX34.820.14
+0.40%
Green Century Balanced
IGMIX9.820.03
+0.31%
Voya Global Insights Portfolio I
TFSCX16.140.03
+0.19%
Templeton Ins Foreign Smaller Co Ser Adv
GICCX12.23N/A
N/A
Goldman Sachs Intl Sm Cp Insghts C

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-1.08%
DNLI - ACLX
49%
Loosely correlated
+1.17%
KYMR - ACLX
47%
Loosely correlated
+0.98%
RCKT - ACLX
47%
Loosely correlated
+3.15%
RCUS - ACLX
46%
Loosely correlated
-5.23%
BEAM - ACLX
46%
Loosely correlated
+7.58%
More

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-0.92%
KYMR - ATXS
47%
Loosely correlated
+0.98%
KALV - ATXS
44%
Loosely correlated
-2.17%
IMNM - ATXS
44%
Loosely correlated
+0.39%
ORIC - ATXS
42%
Loosely correlated
-1.30%
ACLX - ATXS
42%
Loosely correlated
-1.08%
More